CIK: 0001012622 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value ($000): $875,576,705 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACCELERATE DIAGNOSTICS INC | 4,778,049 | $104,209,249 | 11.9% | $21810.00 | — | COM | 00430H102 |
| — | QUIDEL CORP | 3,256,957 | $88,914,926 | 10.2% | $25530.00 | — | COM | 74838J101 |
| THC | TENET HEALTHCARE CORP | 1,755,950 | $75,172,219 | 8.6% | $44.12 | 0.0% | COM NEW | 88033G407 |
| — | ACORDA THERAPEUTICS INC | 1,956,414 | $74,167,655 | 8.5% | $32990.00 | — | COM | 00484M106 |
| — | MAZOR ROBOTICS LTD | 3,194,562 | $65,296,847 | 7.5% | $15378.05 | — | SPONSORED ADS | 57886P103 |
| — | THORATEC CORP | 1,756,204 | $62,889,665 | 7.2% | $32196.16 | — | COM NEW | 885175307 |
| OPK | OPKO HEALTH INC | 5,571,960 | $51,930,667 | 5.9% | $6.91 | +26.9% | COM | 68375N103 |
| — | HANSEN MEDICAL INC | 19,658,147 | $51,111,182 | 5.8% | $1659.47 | — | COM | 411307101 |
| — | NXSTAGE MEDICAL INC | 3,599,192 | $45,853,706 | 5.2% | $13072.05 | — | COM | 67072V103 |
| — | TRANSITION THERAPEUTICS INC | 4,287,412 | $34,170,674 | 3.9% | $3381.69 | — | COM NEW | 893716209 |
| ARAY | ACCURAY INC | 3,240,006 | $31,104,058 | 3.6% | $5.36 | +76.3% | COM | 004397105 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,846,005 | $22,742,782 | 2.6% | $11.76 | -4.4% | COM CL A | 46333X108 |
| — | REPROS THERAPEUTICS INC | 1,242,326 | $22,038,863 | 2.5% | $17740.00 | — | COM NEW | 76028H209 |
| — | VERMILLION INC | 7,139,960 | $21,062,882 | 2.4% | $1988.82 | — | COM NEW | 92407M206 |
| — | TESARO INC | 633,752 | $18,683,009 | 2.1% | $32206.32 | — | COM | 881569107 |
| — | ENDOCYTE INC | 670,000 | $15,952,700 | 1.8% | $23810.00 | — | COM | 29269A102 |
| — | BIOLASE INC | 6,135,910 | $14,787,543 | 1.7% | $2597.75 | — | COM | 090911108 |
| — | INTREXON CORP | 550,000 | $14,459,500 | 1.7% | $23797.65 | — | COM | 46122T102 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 2,575,729 | $13,780,150 | 1.6% | $2.99 | +111.3% | COM | 69404D108 |
| — | WEBMD HEALTH CORP | 300,141 | $12,425,837 | 1.4% | $31784.04 | — | COM | 94770V102 |
| — | GENTIVA HEALTH SERVICES INC | 847,600 | $7,730,112 | 0.9% | $9960.00 | — | COM | 37247A102 |
| — | DERMA SCIENCES INC | 500,000 | $6,340,000 | 0.7% | $12680.00 | — | COM PAR $.01 | 249827502 |
| — | AMARIN CORP PLC | 3,000,000 | $5,430,000 | 0.6% | $1810.00 | — | SPONS ADR NEW | 023111206 |
| — | AGENUS INC | 1,375,634 | $4,360,763 | 0.5% | $3170.00 | — | COM NEW | 00847G705 |
| AGIO | AGIOS PHARMACEUTICALS INC | 100,000 | $3,915,000 | 0.4% | $33.46 | 0.0% | COM | 00847X104 |
| BIIB | BIOGEN IDEC INC | 11,530 | $3,526,681 | 0.4% | $213.68 | +48.6% | COM | 09062X103 |
| — | METABOLIX INC | 1,658,126 | $2,155,564 | 0.2% | $1420.00 | — | COM | 591018809 |
| — | GTX INC DEL | 497,769 | $761,587 | 0.1% | $6600.00 | — | COM | 40052B108 |
| — | LADENBURG THALMAN FIN SVCS I | 166,849 | $503,884 | 0.1% | $1650.00 | — | COM | 50575Q102 |
| GILD | GILEAD SCIENCES INC | 50,000 | $99,000 | 0.0% | $54.49 | 0.0% | COM | 375558103 |